CAP1 and breast cancer: Secondly, the phosphor-regulation mechanism of CAP1, as well as the responsible phosphor-regulatory cell signals that are identified, may help to develop strategies for targeting CAP1 in breast cancer therapeutics without directly targeting the cytoskeletal protein.